Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

BACTOCILL

OXACILLIN SODIUM

Standard Dose
EQ 250MG BASE/5ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview BACTOCILL is listed in Drugs@FDA under application 062321 (ANDA).

Marketing status: Discontinued Active ingredient OXACILLIN SODIUM Form and strength FOR SOLUTION;ORAL - EQ 250MG BASE/5ML Sponsor GLAXOSMITHKLINE Submission history Latest submission status date: 1981-06-02 00:00:00.

Structured Monograph

Clinical summary

Approval overview BACTOCILL is listed in Drugs@FDA under application 062321 (ANDA). Marketing status: Discontinued Active ingredient OXACILLIN SODIUM Form and strength FOR SOLUTION;ORAL - EQ 250MG BASE/5ML Sponsor GLAXOSMITHKLINE Submission history Latest submission status date: 1981-06-02 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.